Here are four takeaways:
1. The company recently reported good first quarter financial results, up from the same period in 2015.
2. Approximately 4.77 million shares traded hands, up 87.8 percent from the average.
3. Since Oct. 5, 2015, the company has decreased 27.03 percent.
4. Cytori has underperformed the S&P500 by 31.92 percent.
More articles on devices:
Exactech insider sells 3.9k shares — 4 notes
4 trends in outpatient spine surgery from Amendia
Xtant Medical CEO buys company shares worth $11k+: 4 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
